Latest Revenue Growth News

Synertec Corporation has affirmed that its recent announcements on a $4 million AGL contract and a 40-50% revenue growth forecast for FY27 were material and disclosed promptly, maintaining confidentiality until release.

Aerometrex expects FY26 EBITDA to more than double, driven by strong MetroMap subscription growth and record revenue, signalling a pivotal step in its SaaS transition.

Aura Consolidated Group delivers strong pro forma Q2 2026 results with 27% revenue growth and a 51% improvement in adjusted EBITDA following its acquisition of Qoria.

ClearVue Technologies has secured Clean Energy Council approval for its ClearVue-Helios rooftop solar panels, enabling government subsidies and grid connection in Australia. This certification coincides with expanded commercial solar incentives, potentially lowering costs for customers.

Kinatico Limited reports a robust FY26 with SaaS revenue growth driving total revenue up 9.4% to $35.2 million and net profit after tax soaring 78.5% to $2.0 million, underpinned by its AI-native compliance platform.

REA Group Ltd (ASX:REA) posted a robust FY26 with revenue up 7% to A$1.793 billion and core net profit rising 15% to A$682 million, supported by record audience engagement and strategic AI investments.

Light & Wonder's Q2 2026 sees net income jump 26% to $120 million, driven by strong Gaming and iGaming growth. The company sticks to its 2026 outlook, targeting mid- to high-single-digit EBITDA growth and aims to reduce leverage below 3.0x by mid-2027.

AoFrio’s revenue fell 21.5% in 1H26, dragged down by a 50.5% plunge in motor sales due to US tariffs, while IoT revenue grew modestly. The company launched new cellular and software platforms, raised NZD 8.9 million, and is expanding into Food Retail, but full-year revenue growth now looks unlikely.

Lumos Diagnostics has landed a US$767,800 purchase order for its FebriDx rapid test from PHASE Scientific, marking a key step in commercialising its FDA-approved product ahead of the US flu season.

Vitrafy Life Sciences reported an 80% revenue surge and halved its net loss, buoyed by US military validation and major blood network partnerships. A $32 million capital raise fuels its US commercial expansion and manufacturing scale-up.

Reckon Limited maintained steady revenue and EBITDA in constant currency during the first half of FY26, while NPAT rose 6%, driven by strong growth in its cloud products Reckon One and Billing Workflows alongside strategic AI investments.

Mayfield Group Holdings has finalized its acquisition of Nilsen's Switchboards Division, adding skilled staff and new product lines to boost manufacturing capacity and revenue growth prospects for FY27.